Table 5.
Conservation of positioning between normal prostate tissues and in benign disease.
| Tissue | SP100 | TGFB3 | SATB1 | LMNA |
|---|---|---|---|---|
| N1 | ||||
| N2 | P | |||
| N3 | P | |||
| N4 | ||||
| N5 | ||||
| N6 | ||||
| N7 | ||||
| N8 | ||||
| N9 | ||||
| N10 | ||||
| N11 | ||||
| N12 | ||||
| N13 | ||||
| N14 | ||||
| N15 | ||||
| N16 | ||||
| B1 | I | |||
| B2 | ||||
| B3 | I | I | ||
| B4 | ||||
| B5 | ||||
| B6 | ||||
| B7 | ||||
| B8 | ||||
| B9 |
Statistical comparisons of the RRD of a gene in individual benign tissues and to the PND, using the two-sample 1D KS test. Red, significantly different (P < 0.01); Blue, statistically similar position (P > 0.01). N1-16, normal prostate tissue; B1-9, benign disease tissues; I, a more internal position in the benign, compared to the PND; P, a more peripheral positioning in the benign tissue.